厦门信达(000701) - 2022 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2022 was ¥27,789,413,345.52, a decrease of 20.15% compared to the same period last year[3]. - The net profit attributable to shareholders was -¥3,769,782.60, representing a decline of 109.19% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥104,141,215.60, a decrease of 313.93% compared to the previous year[3]. - The operating revenue for the period was CNY 74.92 billion, a decrease of about 10.8% compared to CNY 83.93 billion in the previous period[22]. - The total operating costs were CNY 74.93 billion, down from CNY 83.44 billion, showing a reduction of approximately 10.3%[22]. - The net profit for Q3 2022 was 96,048,889.43 CNY, down from 122,932,663.43 CNY in the same period last year, indicating a decrease of about 22%[23]. - The operating profit for Q3 2022 was 187,957,392.23 CNY, compared to 238,977,303.72 CNY in Q3 2021, reflecting a decline of approximately 21.4%[23]. - The total comprehensive income for Q3 2022 was 191,323,691.77 CNY, compared to 119,297,901.31 CNY in Q3 2021, an increase of approximately 60.4%[24]. Cash Flow and Investments - The company's cash flow from operating activities showed a net outflow of -¥1,831,069,381.72, a decline of 189.49% year-on-year[3]. - The net cash flow from operating activities for the first nine months of 2022 was -CNY 1,831,069,381.72, a decrease of 189.49% year-on-year[8]. - The net cash flow from investing activities improved by 62.41%, amounting to -CNY 470,627,846.20 for the first nine months of 2022[8]. - The investment activities generated a net cash flow of -470,627,846.20 CNY in Q3 2022, an improvement from -1,252,116,268.14 CNY in Q3 2021[27]. - The net cash flow from financing activities decreased by 48.53%, totaling CNY 1,479,258,086.12 in the first three quarters of 2022[8]. - The financing activities generated a net cash flow of 1,479,258,086.12 CNY in Q3 2022, down from 2,874,221,836.60 CNY in Q3 2021[28]. Assets and Liabilities - The total assets at the end of the reporting period were ¥21,457,452,898.51, an increase of 36.56% from the end of the previous year[4]. - As of September 30, 2022, the total assets of Xiamen Xinda Co., Ltd. reached CNY 21.46 billion, an increase from CNY 15.71 billion at the beginning of the year, representing a growth of approximately 36.5%[18]. - The company's total liabilities amounted to CNY 17.88 billion, up from CNY 12.22 billion at the beginning of the year, indicating an increase of about 46.2%[20]. - The total equity of the company as of September 30, 2022, was CNY 3.58 billion, compared to CNY 3.49 billion at the beginning of the year, reflecting a growth of approximately 2.5%[20]. Receivables and Inventory - The company's accounts receivable increased by 72.66% to ¥3,559,035,272.26 compared to the end of 2021[7]. - The accounts receivable increased significantly to CNY 3.56 billion from CNY 2.06 billion, marking an increase of about 72.5%[18]. - The inventory level rose significantly by 139.96% to ¥5,594,252,337.66 compared to the end of the previous year[7]. Financial Expenses and Income - Financial expenses for the first nine months of 2022 were ¥554,647,063.72, an increase of 84.90% year-on-year[7]. - Financial expenses increased due to exchange losses from RMB depreciation, prompting the company to use financial instruments to hedge against currency risks[9]. - The company recognized an increase in government subsidies received, contributing to other income growth during the reporting period[9]. - The company reported a total of ¥100,371,433.00 in non-recurring gains for the current period[5]. - Investment income for the first three quarters of 2022 was CNY 332,391,042.43, an increase of 259.85% compared to the same period in 2021[8]. - The company reported a significant increase in other comprehensive income after tax, amounting to CNY 95,274,802.34, a rise of 2,721.21% compared to the previous year[8]. Shareholder Actions - The company completed the repurchase and cancellation of 460,000 shares of restricted stock at a price of CNY 2.46 per share due to the departure of 5 incentive plan participants[15]. - The company granted 25.98 million shares of restricted stock to 253 incentive plan participants under the 2022 incentive plan[16]. Research and Development - Research and development expenses for Q3 2022 were 39,988,938.76 CNY, down from 46,899,559.21 CNY in Q3 2021, a decrease of about 14.7%[23].